HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Rare complications after second hematopoietic stem cell transplantation for thalassemia major.

Abstract
We describe an 11-year-old girl with thalassemia major who underwent a second hematopoietic stem cell transplantation from a matched related donor and who subsequently developed posttransplant lymphoproliferative disorder complicated by severe ascending paralysis resembling Guillian-Barré syndrome. Six months later she developed a massive pericardial effusion. She received a multimodal treatment for these complications and currently, 18 months after transplantation, she is in a good clinical condition, is transfusion independent, with no evidence of graft-versus-host disease and off all treatment. This case highlights the dilemma surrounding second hematopoietic stem cell transplantations in hemoglobinopathies and the need for a careful, well informed, and collaborative decision-making process by patients, families, and medical professionals.
AuthorsAsaf Yanir, Ido Yatsiv, Jacques Braun, Amir Zilkha, Rebecca Brooks, Dalia Bouhanna, Michael Weintraub, Polina Stepensky
JournalJournal of pediatric hematology/oncology (J Pediatr Hematol Oncol) Vol. 34 Issue 5 Pg. e209-11 (Jul 2012) ISSN: 1536-3678 [Electronic] United States
PMID22395220 (Publication Type: Case Reports, Journal Article)
Topics
  • Child
  • Female
  • Hematopoietic Stem Cell Transplantation (adverse effects)
  • Humans
  • Transplantation Conditioning
  • beta-Thalassemia (surgery)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: